BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9297556)

  • 1. Apoptotic death induced in MOLT-4 T-lymphoblasts by purine nucleoside phosphorylase inhibition.
    Gilbertsen RB; Posmantur R; Nath R; Wang KK
    Inflamm Res; 1997 Aug; 46 Suppl 2():S151-2. PubMed ID: 9297556
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor.
    Gilbertsen RB; Scott ME; Dong MK; Kossarek LM; Bennett MK; Schrier DJ; Sircar JC
    Agents Actions; 1987 Aug; 21(3-4):272-4. PubMed ID: 3120507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells.
    Posmantur R; Wang KK; Nath R; Gilbertsen RB
    Immunopharmacology; 1997 Oct; 37(2-3):231-44. PubMed ID: 9403342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
    Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
    J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro study of BCX-34: a new human T-lymphocyte-specific purine phosphorylase inhibitor.
    Iwata H; Wada Y; Walsh M; Montgomery JA; Hirose H; Mendez R; Cicciarelli J; Iwaki Y
    Transplant Proc; 1998 Jun; 30(4):983-6. PubMed ID: 9636397
    [No Abstract]   [Full Text] [Related]  

  • 6. Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes.
    Kicska GA; Long L; Hörig H; Fairchild C; Tyler PC; Furneaux RH; Schramm VL; Kaufman HL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4593-8. PubMed ID: 11287638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 8-Amino-9-substituted guanines: potent purine nucleoside phosphorylase (PNP) inhibitors.
    Sircar JC; Kostlan CR; Pinter GW; Suto MJ; Bobovski TP; Capiris T; Schwender CF; Dong MK; Scott ME; Bennett MK
    Agents Actions; 1987 Aug; 21(3-4):253-6. PubMed ID: 3120506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of human purine nucleoside phosphorylase. Synthesis, purine nucleoside phosphorylase inhibition, and T-cell cytotoxicity of 2,5-diaminothiazolo[5,4-d]pyrimidin-7(6H)-one and 2,5-diaminothiazolo[4,5-d]pyrimidin-7(6H)-one. Two thio isosteres of 8-aminoguanine.
    Sircar JC; Suto MJ; Scott ME; Dong MK; Gilbertsen RB
    J Med Chem; 1986 Sep; 29(9):1804-6. PubMed ID: 3091835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts.
    Kazmers IS; Mitchell BS; Dadonna PE; Wotring LL; Townsend LB; Kelley WN
    Science; 1981 Dec; 214(4525):1137-9. PubMed ID: 6795718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955.
    Gilbertsen RB; Josyula U; Sircar JC; Dong MK; Wu WS; Wilburn DJ; Conroy MC
    Biochem Pharmacol; 1992 Sep; 44(5):996-9. PubMed ID: 1530667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of two 9-deazaguanine analogue inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955, in vitro and in vivo.
    Gilbertsen RB; Dong MK; Josyula U; Sircar JC; Wilburn DJ; Conroy MC
    Ann N Y Acad Sci; 1993 Jun; 685():248-51. PubMed ID: 8363228
    [No Abstract]   [Full Text] [Related]  

  • 12. The biochemical and pharmacological activity of 9-benzyl-9-deazaguanine, a potent purine nucleoside phosphorylase (PNP) inhibitor.
    Kimble E; Hadala J; Ludewig R; Peters P; Greenberg G; Xiao G; Guida W; McQuire L; Simon P
    Inflamm Res; 1995 Aug; 44 Suppl 2():S181-2. PubMed ID: 8548387
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972.
    Gilbertsen RB; Dong MK; Kossarek LM; Sircar JC; Kostlan CR; Conroy MC
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1351-8. PubMed ID: 1908235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferation.
    Boehncke WH; Gilbertsen RB; Hemmer J; Sterry W
    Scand J Immunol; 1994 Mar; 39(3):327-32. PubMed ID: 8128192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of immunosuppressive agents on human T and B lymphoblasts.
    Kazmers IS; Daddona PE; Dalke AP; Kelley WN
    Biochem Pharmacol; 1983 Mar; 32(5):805-10. PubMed ID: 6404281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of 2'-deoxyguanosine cytotoxicity by a novel inhibitor of purine nucleoside phosphorylase, 8-amino-9-benzylguanine.
    Shewach DS; Chern JW; Pillote KE; Townsend LB; Daddona PE
    Cancer Res; 1986 Feb; 46(2):519-23. PubMed ID: 3079664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential metabolism of guanine nucleosides by human lymphoid cell lines.
    Mitchell BS; Sidi Y
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):427-31. PubMed ID: 3875100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for distinct catabolic pathways for deoxy-GTP and GTP in purine-nucleoside phosphorylase-deficient mouse T lymphoblasts.
    Barankiewicz J; Cohen A
    J Biol Chem; 1985 Apr; 260(8):4565-7. PubMed ID: 2985556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacological properties of CI-972, a novel 9-deazaguanine analog purine nucleoside phosphorylase (PNP) inhibitor.
    Gilbertsen RB; Dong MK; Wilburn DJ; Kossarek LM; Sircar JC; Kostlan CR; Conroy MC
    Adv Exp Med Biol; 1991; 309A():41-4. PubMed ID: 1789255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2-d] pyrimidin-4-one.
    Sircar JC; Kostlan CR; Gilbertsen RB; Bennett MK; Dong MK; Cetenko WJ
    J Med Chem; 1992 May; 35(9):1605-9. PubMed ID: 1578487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.